Home > Qtrly Results > NATCO PHARMA

NATCO PHARMA
Quarterly Results Analysis [Mar2025]

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹1,221 Cr ₹475 Cr ₹1,371 Cr ₹1,363 Cr ₹1,068 Cr ₹759 Cr ₹1,031 Cr ₹1,141 Cr
Expenses ₹673 Cr ₹436 Cr ₹567 Cr ₹558 Cr ₹571 Cr ₹491 Cr ₹573 Cr ₹613 Cr
Operating Income ₹548 Cr ₹39 Cr ₹804 Cr ₹805 Cr ₹497 Cr ₹268 Cr ₹458 Cr ₹528 Cr
Other Income ₹66 Cr ₹176 Cr ₹64 Cr ₹48 Cr ₹42 Cr ₹37 Cr ₹29 Cr ₹20 Cr
Interest ₹10 Cr ₹4 Cr ₹4 Cr ₹5 Cr ₹6 Cr ₹5 Cr ₹4 Cr ₹4 Cr
Depreciation ₹98 Cr ₹47 Cr ₹46 Cr ₹44 Cr ₹56 Cr ₹44 Cr ₹44 Cr ₹44 Cr
Profit Before Tax ₹506 Cr ₹164 Cr ₹818 Cr ₹804 Cr ₹478 Cr ₹256 Cr ₹440 Cr ₹500 Cr
Profit After Tax ₹406 Cr ₹132 Cr ₹677 Cr ₹669 Cr ₹386 Cr ₹213 Cr ₹369 Cr ₹420 Cr
EPS ₹22.72 ₹7.43 ₹37.84 ₹37.35 ₹21.58 ₹11.88 ₹20.61 ₹23.48
Industry Peers & Returns1W1M1Y
NATCO PHARMA 5.7% 10.8% -15.8%
SUN PHARMACEUTICAL INDUSTRIES -0.3% -2.9% 11.5%
DIVIS LABORATORIES 0.7% 7.4% 48.1%
CIPLA -0.1% 0.2% -2.1%
TORRENT PHARMACEUTICALS 2.3% -0.5% 13.8%
DR REDDYS LABORATORIES 3.2% 10.3% 11.7%
MANKIND PHARMA 1.1% -7% 9.7%
ZYDUS LIFESCIENCES 0.2% 7.8% -9.8%
LUPIN 0.3% -3.4% 23.6%

NATCO PHARMA Quarterly Revenues

Revenues
Q-o-Q

157.16 %

Y-o-Y

14.29 %

Quarters Revenues % Change
Mar2025 ₹1,221 Cr
157.16
Dec2024 ₹475 Cr
-65.37
Sep2024 ₹1,371 Cr
0.62
Jun2024 ₹1,363 Cr
27.55
Mar2024 ₹1,068 Cr
40.83
Dec2023 ₹759 Cr
-26.45
Sep2023 ₹1,031 Cr
-9.57
Jun2023 ₹1,141 Cr -

NATCO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

1,312.63 %

Y-o-Y

10.22 %

Quarters Operating Profit % Change
Mar2025 ₹548 Cr
1,312.63
Dec2024 ₹39 Cr
-95.18
Sep2024 ₹804 Cr
-0.06
Jun2024 ₹805 Cr
61.83
Mar2024 ₹497 Cr
85.49
Dec2023 ₹268 Cr
-41.46
Sep2023 ₹458 Cr
-13.26
Jun2023 ₹528 Cr -
Operating Margins
Q-o-Q

449.45 %

Y-o-Y

-3.57 %

Quarters Operating Margin% % Change
Mar2025 44.89%
449.45
Dec2024 8.17%
-86.07
Sep2024 58.66%
-0.68
Jun2024 59.06%
26.87
Mar2024 46.55%
31.72
Dec2023 35.34%
-20.42
Sep2023 44.41%
-4.08
Jun2023 46.3% -

NATCO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

206.65 %

Y-o-Y

5.10 %

Quarters Profit After Tax % Change
Mar2025 ₹406 Cr
206.65
Dec2024 ₹132 Cr
-80.43
Sep2024 ₹677 Cr
1.20
Jun2024 ₹669 Cr
73.05
Mar2024 ₹386 Cr
81.62
Dec2023 ₹213 Cr
-42.36
Sep2023 ₹369 Cr
-12.21
Jun2023 ₹420 Cr -
PAT Margins
Q-o-Q

19.22 %

Y-o-Y

-8.05 %

Quarters PAT Margin(%) % Change
Mar2025 33.25 %
19.22
Dec2024 27.89 %
-43.47
Sep2024 49.34 %
0.57
Jun2024 49.06 %
35.67
Mar2024 36.16 %
28.96
Dec2023 28.04 %
-21.63
Sep2023 35.78 %
-2.90
Jun2023 36.85 % -

NATCO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

205.79 %

Y-o-Y

5.28 %

Quarters EPS % Change
Mar2025 ₹22.72
205.79
Dec2024 ₹7.43
-80.36
Sep2024 ₹37.84
1.31
Jun2024 ₹37.35
73.08
Mar2024 ₹21.58
81.65
Dec2023 ₹11.88
-42.36
Sep2023 ₹20.61
-12.22
Jun2023 ₹23.48 -

You may also like the below Video Courses